Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial

Table 1

BCVA logMAR after intervention for both groups.

Time	Control		Intervention		P1
	Mean	SD	Mean	SD
Baseline	0.181	0.0911	0.213	0.0806	0.270
Month 1	0.206	0.1063	0.225	0.0931	0.539
Month 2	0.213	0.0957	0.231	0.0946	0.642
P2	0.115		0.247

SD: standard deviation, P₁: between-group value (Mann–Whitney test), P₂: within-group value (Friedman test).